Skip to main content
Log in

Hepatitis B vaccination campaign in a low endemicity area

  • Short Reports
  • Published:
European Journal of Clinical Microbiology Aims and scope Submit manuscript

Abstract

Between January 1982 and December 1983 14,666 high-risk individuals in the Canton of Zurich, which has one million inhabitants, received 36,234 hepatitis B vaccine injections. The annual number of acute hepatitis B cases dropped from an estimated 220 to 280 in 1981 to 177 in 1982 and 133 in 1983. This drop of 40–50 % resulted mainly from reduced numbers of cases among health care workers, drug addicts and homosexuals. Vaccination was a factor responsible for the reduced incidence of hepatitis B among health care workers and drug addicts, high-risk categories substantial proportions of which had been vaccinated. There was no evidence of a secondary protective effect of vaccination extending to other high-risk groups.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Grob, P. J., Rickenbach, M., Wagner, S., Steffen, R., Gutzwiller, F.: Hepatitis B vaccination of high-risk individuals in the Canton of Zurich. European Journal of Clinical Microbiology 1983, 2: 309–315.

    PubMed  Google Scholar 

  2. Widmer, U. K., Villaverde, A., Grob, P. J.: Hepatitisepidemiologie 1977 bis 1979. Schweizerische Medizinische Wochenschrift 1980, 110: 930–937.

    PubMed  Google Scholar 

  3. Advisory Committee of Immunization Practices: Inactivated hepatitis B virus vaccine. Morbidity and Mortality Weekly Report 1982, 31: 317–322, 327–329.

    Google Scholar 

  4. Grob, P. J.: The significance of hepatitis B infection in patients on hemodialysis or with renal transplants. In: Krugman, S., Sherlock, S. (ed.): Proceedings of the European Symposium on Hepatitis B. Merck, Sharp & Dohme International, New York, 1981, p. 39–53.

    Google Scholar 

  5. Blumer, U., Schär, M., Grob, P. J.: Gassenimpfung. Sozialund Präventivmedizin 1984, 29: 187–188.

    Google Scholar 

  6. Grob, P. J., Binswanger, U., Zaxuba, K., Joller-Jemelka, H. I., Schmid, M., Häcki, W., Blumberg, A., Abplanalp, A., Herwig, W., Iselin, H., Descoeudres, C.: Immunogenicity of a hepatitis B subunit vaccine in hemodialysis and in renal transplant recipients. Antiviral Research 1983, 3: 43–52.

    PubMed  Google Scholar 

  7. Szmuness, W., Stevens, C. E., Harley, E. J., Zang, E. A., Oleszko, W. R., William, D. C., Sadovsky, R., Morrison, J. M., Kellner, A.: Hepatitis B vaccine. Demonstration of efficacy in a controlled clinical trial in a high-risk population in the United States. New England Journal of Medicine 1980, 303: 833–841.

    PubMed  Google Scholar 

  8. Crosnier, J., Jungers, P., Couccoucé, A. M., Laplanche, A., Benhamou, E., Degos, F., Lacour, B., Prunet, P., Cerisier, Y., Guesry, P.: Randomised placebo-controlled trial of hepatitis B surface antigen vaccine in French haemodialysis units. II: Haemodialysis patients. Lancet 1981, i: 797–800.

    Google Scholar 

  9. Desmyter, J., De Groote, G., Colaert, J.: Efficacy of heat-inactivated hepatitis B vaccine in haemodialysis patients and staff. Lancet 1983, ii: 1323–1328.

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Grob, P.J., Rickenbach, M., Steffen, R. et al. Hepatitis B vaccination campaign in a low endemicity area. Eur. J, Clin. Microbiol. 4, 408–411 (1985). https://doi.org/10.1007/BF02148694

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF02148694

Keywords

Navigation